Tom Perdue
Overview
Explore the profile of Tom Perdue including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
206
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kohler P, Namate D, Barnhart S, Chimbwandira F, Tippet-Barr B, Perdue T, et al.
BMC Health Serv Res
. 2016 Feb;
16:61.
PMID: 26888178
Background: Assessing safety outcomes is critical to inform optimal scale-up of voluntary medical male circumcision (VMMC) programs. Clinical trials demonstrated adverse event (AE) rates from 1.5 to 8 %, but...
2.
Latkin C, Donnell D, Metzger D, Sherman S, Aramrattna A, Davis-Vogel A, et al.
Soc Sci Med
. 2008 Dec;
68(4):740-8.
PMID: 19070413
This HIV Prevention Trials Network study assessed the efficacy of a network-oriented peer education intervention promoting HIV risk reduction among injection drug users and their drug and sexual network members...
3.
Shaboltas A, Toussova O, Hoffman I, Heimer R, Verevochkin S, Ryder R, et al.
J Acquir Immune Defic Syndr
. 2006 May;
41(5):657-63.
PMID: 16652041
Objective: In St. Petersburg, Russia, we sought to describe the characteristics of active high-risk injection drug users (IDUs) to evaluate the associations between behavioral and demographic characteristics and HIV-1 infection...
4.
Kozlov A, Shaboltas A, Toussova O, Verevochkin S, Masse B, Perdue T, et al.
AIDS
. 2006 Mar;
20(6):901-6.
PMID: 16549975
Background: The Russian HIV-1 epidemic has been driven by injection drug use. Objective: To determine HIV incidence and identify demographic and behavioral correlates of infection to facilitate the development of...